Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer

This publication has 13 references indexed in Scilit:

• Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911
  Journal of Urology, 1997
• A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer
  Journal of Urology, 1996
• A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma
  Journal of Urology, 1996
• Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer
  Urology, 1995
• Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study
  Urologic Oncology: Seminars and Original Investigations, 1995
• Improving the Efficacy of BCG Immunotherapy by Dose Reduction
  European Urology, 1995
• Bacillus Calmette-Guérin versus mitomycin intravesical therapy in superficial bladder cancer: Results of randomized trial after 21 months of follow-up
  Urology, 1992
• Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder Cancer
  European Urology, 1991
• Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel Procedure
  Journal of the American Statistical Association, 1963
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958